TWM
RXRX icon

Tradition Wealth Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Tradition Wealth Management’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.83K Hold
500
– – ﹤0.01% 559
2026
Q1 		$1.53K Buy
+500
New +$1.93K ﹤0.01% 526

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Tradition Wealth Management's RXRX Position: Q2 2026 in Review

Tradition Wealth Management reduced its Recursion Pharmaceuticals (RXRX) stake by 21% in Q2 2026, selling an estimated $46.9K and leaving 53,657 shares worth $197K. The position accounts for 0.01% of the portfolio, ranked #509.

Tradition Wealth Management first reported a position in RXRX in Q3 2023 and has held it in 6 quarters since. The position peaked at $272K in Q4 2025. 343 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • Tradition Wealth Management held 53,657 shares of Recursion Pharmaceuticals worth $197K as of Q2 2026.
  • Tradition Wealth Management sold 14,081 Recursion Pharmaceuticals shares in Q2 2026, an estimated $46.9K.
  • Recursion Pharmaceuticals made up 0.01% of Tradition Wealth Management's portfolio in Q2 2026, its #509 holding.
  • Tradition Wealth Management first reported a position in Recursion Pharmaceuticals in Q3 2023 and has held it in 6 quarters since.
  • Tradition Wealth Management's Recursion Pharmaceuticals position peaked at $272K in Q4 2025.
  • 343 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Tradition Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.